It's interesting when a drug is re-purposed into something aimed at fighting cancer, but that is what has happened to Evista, a prescription drug made by Eli Lilly which was originally for osteoporosis patients.The FDA has officially approved Evista for use in breast cancer patients as of late this week, although the drug will now come with a box warning advising patients of a heightened risk for stroke by taking the drug.
I'm not sure -- are some drugs worth the possible benefits when certain side effects can be just as bad as what is trying to be treated?
Eli Lilly's Evista breast cancer drug has seen sharp criticism from womens' groups and more -- and has seen opposition from the FDA as well. The drug, nevertheless, may be approved by an FDA panel soon. What would most likely follow would be official FDA approval, which means the drug would then be free to be marketed and prescribed.
